Scientific article 1. MAY 2013

Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab

The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial

Authors:

  • Casper Steenholdt
  • Jorn Brynskov
  • Ole Thomsen
  • Lars K. Munck
  • Jan Fallingborg
  • Lisbet A. Christensen
  • Gitte Pedersen
  • Jens Kjeldsen
  • Bent A. Jacobsen
  • Anne Sophie Oxholm
  • Jakob Kjellberg
  • Klaus Bendtzen
  • Mark A. Ainsworth

Authors

  • Casper SteenholdtJorn BrynskovOle ThomsenLars K. MunckJan FallingborgLisbet A. ChristensenGitte PedersenJens KjeldsenBent A. JacobsenAnne Sophie OxholmJakob KjellbergKlaus BendtzenMark A. Ainsworth

About this publication

  • Published in

    Gastroenterology
VIVE – The Danish Centre for Social Science Research provides knowledge that contributes to developing the welfare society and strengthening quality development, efficiency enhancement and governance in the public sector, both in municipalities, regions and nationally.
EAN: 5798000354845
CVR: 23 15 51 17